The authors provide a summary of the regulatory patterns of different programmed cell death (PCD) modes and their potential effects on pulmonary hypertension. Additionally, they describes the current understanding of this complex and interconnected process and analyzes the therapeutic potential of targeting specific PCD modes as molecular targets.
[Cell Death Discovery]